Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2003
03/27/2003WO2003024474A2 Anti-inflammatory agent
03/27/2003WO2003024455A2 Stent coated with a sustained-release drug delivery and method for use thereof
03/27/2003WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2003024424A1 Stabilization of active agents by formulation into nanoparticulate form
03/27/2003WO2003024419A2 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
03/27/2003WO2003024404A2 Chemokines as adjuvants of immune response
03/27/2003WO2003024396A2 Dry powder medicament formulations
03/27/2003WO2003024395A2 Linked biaryl compounds
03/27/2003WO2003024390A2 Hydroxyeicosenoic acid analogs
03/27/2003WO2003024354A2 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2002100334A3 Use of radiopharmaceutical complexes in achieving transplantation tolerance
03/27/2003WO2002094263A3 Caspase inhibitors and uses thereof
03/27/2003WO2002094019A9 Highly purified antiendotoxin compound
03/27/2003WO2002092054A3 Immune modulation device for use in animals
03/27/2003WO2002083870A3 Pufa polyketide synthase systems and uses thereof
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002074332A3 Method to enhance the immunogenicity of an antigen
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002047705A3 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060442 Immunostimulatory cyktokines include interleukins as antitumor agents, dervived from dendritic cells modified via viral vector transduction/centrifugation
03/27/2003US20030060426 Formulation for protection against oxidative stress containing benzofuranone derivatives
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030059937 Antibodies that immunospecifically bind BLyS
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059874 Polypeptide for use in the treatment of autoimmune, inflammatatory, arthritic, atherosclerotic, allergenic, dermatitis, urticaria, adult respiratory distress syndrome, asthma, rhinitis, eczema and infections
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059470 Dispersions for the formulation of slightly or poorly soluble agents
03/27/2003US20030059439 Th1 inducing natural adjuvant for heterologous antigens
03/27/2003US20030059430 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor
03/27/2003US20030059427 Isolation and characterization of highly active anti-CD40 antibody
03/27/2003US20030059424 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
03/27/2003CA2492826A1 Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
03/27/2003CA2486545A1 Peptides capable of modulating immune response
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460719A1 Igf-binding protein-derived peptide or small molecule
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460460A1 Fermentation product of cryptoporus volvatus and its preparation method and use
03/27/2003CA2460392A1 Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460098A1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2457563A1 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003EP1295895A1 Peptides and Protins binding to glu-pro motifs, therapeutical compositions containing them and their applications
03/26/2003EP1295870A1 Suplatast tosilate crystals
03/26/2003EP1295606A1 Curing method for pathologic syndrome and a medicinal preparation
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294904A1 Heterodimeric fusion proteins
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294890A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
03/26/2003EP1294886A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IGE ANTIBODY AND USES THEREOF
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294857A2 Genetically modified t-cells, method for producing them and use thereof
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294769A1 Antibodies that immunospecifically bind to blys
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294758A2 Regulation of human substance p-like g protein-coupled receptor
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294737A1 Antisense modulation of c/ebp beta expression
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 1172